Navoximod

Overview

Navoximod (GDC-0919; NLG-?919) is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with K i / EC 50 of 7 nM/75 nM.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Indoleamine 2,3-Dioxygenase (IDO)

Product Information

• Catalog No.: HY-18770B
• CAS No.: 1402837-78-8
• Molecular Formula: C18H21FN2O2
• Molecular Weight: 316.37
• Purity: 99.99%
• Storage: -20°C, stored under nitrogen * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
• Solubility: ≥ 3 mg/mL (9.48 mM); Clear solution
• Availability: In-stock

Source

Original product source